Rhynchophylline supplier

Name
Rhynchophylline
EINECS
CAS No. 76-66-4
Article Data7
CAS DataBase
Density 1.23 g/cm³
Solubility
Melting Point 216°; mp 197-199° (Ban et al., loc. cit.)
Formula C₂₂H₂₈N₂O₄
Boiling Point 560.8 °C at 760 mmHg
Molecular Weight 384.475
Flash Point 293 °C
Transport Information
Appearance Red brown or white fine powder
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Corynoxan-16-carboxylicacid, 16,17-didehydro-17-methoxy-2-oxo-, methyl ester, (7b,16E,20a)-;Rhyncophylline (6CI,7CI,8CI);Mitrinermine;NSC 21731;Rhynchophyllin;Spiro[3H-indole-3,1'(5'H)-indolizine]-7'-acetic acid, 6'-ethyl-1,2,2',3',6',7',8',8'a-octahydro-a-(methoxymethylene)-2-oxo-,methyl ester, [1'R-[1'a,6'b,7'a(E),8'ab]]-;18.beta.-Glycyrrhetic acid;Mitrinermin;
PSA 67.87000
LogP 2.77610

Rhynchophylline Specification

The Mitrinermin, with the CAS registry number 76-66-4, has the systematic name of methyl (7β,16E,20α)-16-(methoxymethylidene)-2-oxocorynoxan-17-oate. It belongs to the product category of Alkaloids. And the molecular formula of the chemical is C₂₂H₂₈N₂O₄.

The characteristics of Mitrinermin are as followings: (1)ACD/LogP: 3.31; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.57; (4)ACD/LogD (pH 7.4): 2.19; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 14.47; (7)ACD/KOC (pH 5.5): 2.71; (8)ACD/KOC (pH 7.4): 112.79; (9)#H bond acceptors: 6; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 59.08 Å²; (13)Index of Refraction: 1.596; (14)Molar Refractivity: 105.57 cm³; (15)Molar Volume: 310.2 cm³; (16)Polarizability: 41.85×10^-24cm³; (17)Surface Tension: 52.2 dyne/cm; (18)Density: 1.23 g/cm³; (19)Flash Point: 293 °C; (20)Enthalpy of Vaporization: 84.35 kJ/mol; (21)Boiling Point: 560.8 °C at 760 mmHg; (22)Vapour Pressure: 1.32E-12 mmHg at 25°C.

Uses of Mitrinermin: It is always used to treat hypertension, and it is also helpful in treating high blood pressure in I and II period. What's more, it also can improve deformation capacity of red blood cells, and restrain the adverse factors on the erythrocyte deformation ability damage.

Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C2Nc1ccccc1[C@]24[C@H]3N(C[C@@H]([C@@H](C(=C\OC)/C(=O)OC)C3)CC)CC4
(2)InChI: InChI=1/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1
(3)InChIKey: DAXYUDFNWXHGBE-KAXDATADBC

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	134mg/kg (134mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 94, Pg. 17, 1989.
mouse	LD50	intravenous	105mg/kg (105mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 94, Pg. 17, 1989.

Product Name

Rhynchophylline

Rhynchophylline Specification

Related Products

Hot Products